Therefore, the immune checkpoint blockade targeting TIGIT enables a highly powerful T-cell antitumor response in several ways, by restoring the antitumor potential of T effector cells, dampening the Treg immunosuppressive effect, and diminishing the tumor-supporting effects of Tfh cells in FL. This evidence concerns the gene TIGIT and neoplasm.